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carprofen-induced depletion 
of proton motive force reverses 
tetK-mediated doxycycline 
resistance in methicillin-resistant 
Staphylococcus pseudintermedius
Zofia Magnowska1,6*, Bimal Jana1,6, Rikke Prejh Brochmann1,6, Andrew Hesketh  2,3, 
Rene Lametsch4, Cristian De Gobba4 & Luca Guardabassi1,5*
We previously showed that doxycycline (DOX) and carprofen (CPF), a veterinary non-steroidal anti-
inflammatory drug, have synergistic antimicrobial activity against methicillin-resistant Staphylococcus 
pseudintermedius (MRSp) carrying the tetracycline resistance determinant tetK. to elucidate the 
molecular mechanism of this synergy, we investigated the effects of the two drugs, individually 
and in combination, using a comprehensive approach including RNA sequencing, two-dimensional 
differential in-gel electrophoresis, macromolecule biosynthesis assays and fluorescence spectroscopy. 
exposure of tetK-positive MRSp to cpf alone resulted in upregulation of pathways that generate 
ATP and NADH, and promote the proton gradient. We showed that CPF is a proton carrier that 
dissipates the electrochemical potential of the membrane. In the presence of both CPF and DOX, 
the energy compensation strategy was attenuated by downregulation of all the processes involved, 
such as citric acid cycle, oxidative phosphorylation and ATP-providing arginine deiminase pathway. 
Furthermore, protein biosynthesis inhibition increased from 20% under DOX exposure alone to 75% 
upon simultaneous exposure to cpf. We conclude that synergistic interaction of the drugs restores 
DOX susceptibility in MRSP by compromising proton-motive-force-dependent TetK-mediated efflux of 
the antibiotic. MRSp is unable to counterbalance cpf-mediated pMf depletion by cellular metabolic 
adaptations, resulting in intracellular accumulation of DOX and inhibition of protein biosynthesis.
Staphylococci are common colonizers of the skin and mucosae in both humans and animals, and cause a wide 
range of opportunistic infections such as urinary tract, skin and soft-tissue infections, otitis, endocarditis, osteo-
myelitis and sepsis. Historically, β-lactamase-insensitive β-lactam antibiotics exhibited good activity against 
staphylococci but the emergence of methicillin resistance has made them ineffective. Methicillin resistance is 
mediated by the mecA gene, which encodes a modified penicillin-binding protein PBP2a with low affinity for 
all conventional β-lactams1. The global prevalence of methicillin-resistant Staphylococcus aureus (MRSA) and 
methicillin-resistant Staphylococcus pseudintermedius (MRSP) is increasing in both human and veterinary medi-
cine2. Some epidemic MRSP clones such as sequence type (ST)71 are virtually resistant to all antibiotics available 
in veterinary medicine3.
Combination therapy is one of the possible strategies to manage infections caused by multidrug-resistant 
bacteria. In a previous study4, we identified a strong synergy between doxycycline (DOX), a tetracycline anti-
biotic that inhibits bacterial protein synthesis by binding to the 30 S ribosomal subunit, and carprofen (CPF), a 
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veterinary non-steroidal anti-inflammatory drug (NSAID) that inhibits cyclooxygenase activity in eukaryotic 
cells. CPF was previously shown to have antibacterial activity against Escherichia coli by inhibiting DNA polymer-
ase III β subunit (also known as the sliding clamp), which plays an essential role in DNA replication and repair5. 
We showed that co-exposure to CPF restored susceptibility to DOX in DOX-resistant MRSP ST71 containing 
tetK, a tetracycline resistance gene encoding a drug-specific efflux pump6. No synergy was observed for other 
MRSP strains where DOX resistance was mediated by other mechanisms (e.g. ribosomal protection mediated by 
tetM).
The aim of this study was to elucidate the molecular mechanism of synergy between DOX and CPF. The effects 
of the two drugs, individually and in combination, were investigated in DOX-resistant MRSP ST71 using a com-
prehensive systems biology approach consisting of RNA sequencing (RNA-seq), two-dimensional differential 
in-gel electrophoresis (2D DIGE), macromolecule biosynthesis assays and fluorescence spectroscopy.
Results
transcriptomic and proteomic changes following exposure to cpf and/or DoX. RNA-seq and 
2D DIGE were performed to analyse the effects of the two drugs alone and in combination on transcript and pro-
tein abundance, respectively, in the TetK-positive MRSP ST71 model strain E104. Bacterial cultures were sampled 
after 30 min exposure to analyse the early transcriptomic response and after 90 min to examine both transcrip-
tomic and proteomic responses. Supplementary Figure S1 summarise experimental plan for the expression study. 
Transcript abundance data for 2515 genes (for both time points, passing the count filter) and protein abundance 
data for 516 protein spots (passing the Biological Variation Analysis (BVA) gel to gel matching of spots) were used 
for gene expression analysis.
Substantial changes were observed in global gene expression when MRSP E104 was exposed to DOX and 
CPF in combination as compared to individual drug exposure. The numbers of significantly regulated transcripts 
(±2.0-fold change (FC), p < 0.05) and proteins (±1.5-FC, p < 0.05) for CPF and DOX separately and in com-
bination are summarised in Table 1. DOX alone and in combination with CPF caused massive changes in gene 
expression with transcription of a total of 1507 and 1594 different genes changing when considering both the 30 
and 90 min time points, respectively. In comparison, CPF alone changed expression of only 310 unique genes 
in total. The same ratio of proteins regulated by DOX and CPF separately (5:1) was observed in the proteome 
analysis (184/36). Fewer significant changes in transcript abundance were detected after 30 min than after 90 min. 
Supplementary Table S1 presents a list of all genes differentially regulated by CPF and/or DOX.
cpf regulates metabolic pathways associated with cellular energetics. With very few exceptions, 
we did not detect any major transcriptomic changes after 30 min exposure to CPF. The following paragraphs 
mainly refer to the transcriptomic data obtained following 90 min exposure, when alterations in the transcrip-
tome were more frequent than those observed in the proteome. The bacitracin ABC transporter permease bceB 
and bacitracin ABC transporter ATP-binding protein bceA were the genes most intensely induced by CPF, while 
tryptophan biosynthesis was the most notably induced pathway. All genes encoding enzymes catalysing synthesis 
of tryptophan from chorismate (trp ABFCDGE, trpA detected also at the protein level) were strongly upregulated 
after exposure to CPF. As highlighted in the following paragraphs, cellular energetics was the cellular function 
most consistently and strongly impacted by CPF. Table 2 summarizes all the regulated proteins mentioned in the 
omics description.
Central carbon metabolism. Altogether, the expression of 32 genes involved in central carbon metabolism was 
significantly altered (at both transcript and protein level). Substantial and consistent alterations were observed for 
carbohydrate uptake systems. Glucose uptake by the glucose-specific transporter (UH47_06270, UH47_06750) 
was downregulated, whereas expression of numerous alternative carbohydrate carbon source uptake and acti-
vation proteins were triggered, i.e. trehalose (permease, UH47_02750; 6-phosphate hydrolase, treC), glucoside 
(specific transporter, UH47_02965), glucarate (transporter, gudP), glycerol (transporter, glpF; kinase, glpK; dehy-
drogenase, glpA), melibiose (transporter, melB) and gluconate (gluconokinase, gntK). All alternative carbon 
source genes were regulated only after 90 min of exposure to CPF with the exception of those encoding lactate 
permease and glycerol uptake and utilisation enzymes. Only limited changes were observed in the expression of 
genes with functions in glycolysis/gluconeogenesis.
Regulations: DOX CPF DOX-CPF Synergistic interactions
Transcriptome 
30 min
Up 656 22 601 11
Down 464 8 457 14
Sum 1120 30 1058 25
Transcriptome 
90 min
Up 638 156 744 252
Down 590 143 696 228
Sum 1228 299 1440 480
Proteome 
90 min
Up 74 15 102 32
Down 110 21 139 28
Sum 184 36 241 60
Table 1. Summary of gene regulation results associated with exposure to doxycycline (DOX) and/or carprofen 
(CPF) and their synergistic interactions.
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Gene ID Product Name CPF_log2FC Interactions_log2FC
FunctionTime point
T T P T T P
30 90 90 30 90 90
Central metabolism
UH47_06750 PTS system glucose-specific transporter subunit −1 glycolysis
UH47_06270 PTS system glucose-specific transporter subunit −1.2 glycolysis
UH47_12920 glyceraldehyde-3-phosphate dehydrogenase 2.1 −1.5 glycolysis/gluconeogenesis
UH47_11065 phosphoglyceromutase gpmI 1.3 glycolysis/gluconeogenesis
UH47_11070 triosephosphate isomerase tpi −1.2 1.5 1.3 glycolysis/gluconeogenesis
UH47_11075 phosphoglycerate kinase pgk 1.4 1.1 glycolysis/gluconeogenesis
UH47_11085 central glycolytic genes regulator cggR 1 glycolysis
UH47_12460 pyruvate dehydrogenase −1.1 glycolysis
UH47_01940 glucarate transporter gudP 1 −1.2 alternative carbon source
UH47_02965 PTS alpha-glucoside transporter subunit IIBC 1.3 alternative carbon source
UH47_02580 melibiose:sodium symporter melB 1.1 −1.9 alternative carbon source
UH47_02745 trehalose-6-phosphate hydrolase treC 1.7 −2.4 alternative carbon source
UH47_02750 trehalose permease IIC protein 2.6 −3.1 alternative carbon source
UH47_07415 gluconokinase gntK 1.6 −1.4 alternative carbon source
UH47_12030 glycerol-3-phosphate dehydrogenase glpA 2.2 2.5 −2 alternative carbon source
UH47_12040 glycerol transporter glpF 1.8 2.2 −1.9 alternative carbon source
UH47_12035 glycerol kinase glpK 1.3 2.1 −2 alternative carbon source
UH47_00550 C4-dicarboxylate ABC transporter sdcS 1.2 alternative carbon source
UH47_10320 acetyl-CoA synthetase acs 1.7 −2 alternative carbon source
UH47_10480 acetate kinase ackA 1 −0.8 alternat. carbon source/ ferment.
UH47_10315 acetoin dehydrogenase acuA 1.8 −1.2 alternat. carbon source/ ferment.
UH47_10310 acetoin utilization protein AcuC acuC 1.0 alternat. carbon source/ ferment.
UH47_06315 lactate permease lctP 1.2 −1.7 alternat. carbon source/ ferment.
UH47_07720 pyruvate oxidase poxL 1.2 −1.4 alternat. carbon source/ ferment.
UH47_12345 acyl CoA:acetate/3-ketoacid CoA transferase atoD 3 −2.3 alternat. carbon source/ ferment.
UH47_01900 pyruvate formate lyase-activating protein pflA −3 2.9 fermentation
UH47_06300 alcohol dehydrogenase adh −2.2 2.6 fermentation
UH47_12335 butyryl-CoA dehydrogenase −1.5 1.5 fermentation
UH47_05215 succinyl-CoA synthetase subsunit alpha sucD 0.7 −1.6 −0.7 TCA cycle
UH47_05220 succinyl-CoA synthetase subunit beta sucC −1.7 TCA cycle
UH47_05745 succinate dehydrogenase sdhB −1.6 TCA cycle
UH47_05750 succinate dehydrogenase sdhA −1.9 TCA cycle
UH47_06505 malate:quinone oxidoreductase mqo −0.8 TCA cycle
UH47_06710 aconitate hydratase acnA 1.6 −2.4 −2 TCA cycle
UH47_06935 dihydrolipoamide succinyltransferase sucB 1.2 0.8 −1.7 −0.6 TCA cycle
UH47_06940 2-oxoglutarate dehydrogenase sucA 1.3 −1.9 TCA cycle
UH47_10555 citrate synthase gltA 2 −3.1 TCA cycle
UH47_10560 isocitrate dehydrogenase icd 2 −3.4 TCA cycle
UH47_11305 fumarate hydratase fum 1.1 −1.9 TCA cycle
UH47_05755 succinate dehydrogenase sdhC 1 −2.1 TCA cycle/electron transport
Respiration
UH47_10780 ATP synthase F0F1 subunit gamma −1 ATP synthase
UH47_10785 ATP F0F1 synthase subunit alpha −1.1 ATP synthase
UH47_10790 ATP synthase F0F1 subunit delta −1.1 ATP synthase
UH47_09665 2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase menH −1 electron transfer chain
UH47_09670 dihydroxynaphthoic acid synthetase menB −1 electron transfer chain
UH47_06375 FMN-dependent NADH:quinone azoreductase acpD 1.2 1.6 electron transfer chain
UH47_09945 cytochrome bd menaquinol oxidase cydA −2.5 2.6 electron transfer chain
UH47_09950 cytochrome bd menaquinol oxidase cydB −2.7 2.8 electron transfer chain
UH47_01680 nitrate transporter NarT narT 2 nitrate respiration
UH47_01705 nitrate reductase narJ −2.7 2.7 nitrate respiration
UH47_01710 nitrate reductase narH −2.4 2.4 nitrate respiration
UH47_01745 nitrite reductase nirD −2.5 nitrate respiration
Continued
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Gene ID Product Name CPF_log2FC Interactions_log2FC
FunctionTime point
T T P T T P
30 90 90 30 90 90
UH47_08305 formate/nitrite transporter −1.4 2 nitrate respiration
UH47_12325 nitrate ABC transporter substrate-binding protein −1.1 1 nitrate respiration
Amino acid metabolism
UH47_08215 octopine dehydrogenase odh 1.1 −1.1 arginine
UH47_07780 glutamate-1-semialdehyde aminotransferase hemL −1 arginine biosynthesis
UH47_02470 ornithine carbamoyltransferase arcB 3 −1.1 −2.9 arginine utilisation
UH47_06040 arginine deiminase arcA 1.8 −1.2 arginine utilisation
UH47_06025 carbamate kinase arcC −1.1 arginine utilisation
UH47_00790 ornithine cyclodeaminase 1.3 −1.1 arginine/proline
UH47_08665 proline dehydrogenase 2.2 −2.4 arginine/proline
UH47_09190 glutamate dehydrogenase gdhA 1.1 −1.3 arginine/proline
UH47_09195 ornithine–oxo-acid aminotransferase rocD 1.5 −2.1 arginine/proline
UH47_09200 1-pyrroline-5-carboxylate dehydrogenase 1.8 −2.5 arginine/proline
UH47_11985 glutamine synthetase glnA −1.2 −1 0.99 glutamine biosynthesis
UH47_02010 tryptophan synthase subunit alpha trpA 3.6 1 −4.8 −1.2 tryptophan biosynthesis
UH47_02015 tryptophan synthase subunit beta trpB 3.7 −5.4 tryptophan biosynthesis
UH47_02020 N-(5′-phosphoribosyl)anthranilate isomerase trpF 3.7 −5 tryptophan biosynthesis
UH47_02025 indole-3-glycerol phosphate synthase trpC 3.7 −4.4 tryptophan biosynthesis
UH47_02030 anthranilate phosphoribosyltransferase trpD 3.8 −4.5 tryptophan biosynthesis
UH47_02035 anthranilate synthase subunit II trpG 3.7 −4.9 tryptophan biosynthesis
UH47_02040 anthranilate synthase component I trpE 2.8 −3.8 tryptophan biosynthesis
UH47_10825 serine hydroxymethyltransferase glyA −1.7 0.7 glicyne/serine
Lipid metaboism
UH47_02215 triacylglycerol lipase lip 1.5 −1.3 lipid degradation
UH47_12350 long-chain fatty acid–CoA ligase acsL 4.1 −3.4 lipid degradation
Protein synthesis
UH47_11105 Clp protease clpP 0.7 −0.7 folding
UH47_01445 ribosome-associated translation inhibitor raiA 1.1 −1.7 translation
UH47_00215 elongation factor Tu tuf −1.6 translation
UH47_00165 50 S ribosomal protein L1 0.8 translation
UH47_00170 50 S ribosomal protein L10 rplJ 2.1 translation
UH47_00175 50 S ribosomal protein L7/L12 rplL 0.8 translation
UH47_03310 30 S ribosomal protein S6 rpsF 0.8 translation
UH47_05280 50 S ribosomal protein L19 0.7 translation
UH47_07890 30 S ribosomal protein S5 0.8 translation
UH47_11830 50 S ribosomal protein L25 rplY 1.5 translation
UH47_03525 seryl-tRNA synthetase 0.7 translation
UH47_05175 30 S ribosomal protein S2 rpsB 0.6 −0.7 translation
UH47_04780 alanine–tRNA ligase alaS 1.1 translation
UH47_04960 valine–tRNA ligase valS 1 translation
UH47_11775 methionine–tRNA ligase −0.6 0.9 translation
Other proteins
UH47_09860 phosphoribosylformylglycinamidine synthase 1 purine metabolism
UH47_13130 tetracycline resistance protein tetK −1.0 1.1 resistance
UH47_08515 TetR family transcriptional regulator −1.1 1.2 resistance
UH47_00970 bacitracin ABC transporter ATP-binding protein bceA 1.4 4.1 −1.5 −3.8 resistance
UH47_00975 bacitracin ABC transporter permease bceB 1.5 4.3 −1.6 −4 resistance
UH47_03290 catalase katE 1.6 −1.2 stress response
UH47_10565 PhoP family transcriptional regulator phoB −1.2 −1 phosphate starvation regulator
UH47_00025 pyridoxal biosynthesis protein pdxS −1.7 0.9 cofactor biosynthesis
Table 2. Summary list of the genes described in the text presented with significant regulation results associated 
with exposure to CPF and CAR/DOX synergistic interactions. T - transcriptomic and P - proteomics results. 
Complete gene expression data including adjusted p-values are listed in the Supplementary Table S1.
5Scientific RepoRtS |         (2019) 9:17834  | https://doi.org/10.1038/s41598-019-54091-4
www.nature.com/scientificreportswww.nature.com/scientificreports/
Bacterial fermentation pathways regenerate NAD+ reduced during glycolysis in case of deactivated respiration 
processes. We observed downregulation of ethanol (pyruvate-formate lyase, pflA; alcohol dehydrogenase, adh) 
and butyrate (butyryl-CoA dehydrogenase, UH47_12335) fermentation. Moreover, genes involved in uptake and 
utilisation of lactate (permease, lctP), acetate (acetyl-CoA synthetase, acs; pyruvate oxidase, poxL and on protein 
level acetate kinase, ackA) and acetonin (dehydrogenase acuA; utilisation protein acuC, acyl CoA-transferase, 
atoD) were upregulated.
Exposure to CPF consistently induced gene expression for nearly all reactions of the TCA cycle (citrate syn-
thase, gltA; aconitate hydratase, acnA; isocitrate dehydrogenase, icd; 2-oxoglutarate dehydrogenase, sucA; dihy-
drolipoamide succinyltransferase, sucB; succinate dehydrogenase, sdhC; fumarate hydratase, fum). Upregulation 
of succinyl-CoA synthetase subsunit alpha (sucD) and sucB was also observed at the protein level. Only conver-
sion between malate and oxaloacetale was not affected. In addition to the glyceraldehyde 3-phosphate dehydroge-
nase (UH47_12920) enzyme upregulated in glycolysis, two of the reactions upregulated in the TCA cycle increase 
the cellular pool of NADH, one provides FADH2 and the other stores energy in the form of GTP (converti-
ble to ATP). Moreover, aerobic C4-dicarboxylate transporter (sdcS) that supplies the TCA cycle with succinate, 
fumurate and malate was also upregulated. The corresponding anaerobic version of this transporter (dcuA) was 
downregulated.
Respiratory gene expression. BLAST analysis modelled on S. aureus indicated that S. pseudintermedius con-
tains a complete electron transport system and is capable of both aerobic and anaerobic respiration. The electron 
transport chain consists of NADH dehydrogenase (complex I), succinate dehydrogenase (complex II) that prob-
ably, as predicted in S. aureus7, transfers electrons to the lipophilic isoprenoid electron carrier menaquinone. 
Menaquinone passes the electrons on the terminal cytochromes of complex IV where O2 is reduced to H2O. 
Proton motive force (PMF) generated at complex I and IV drives the F0F1 ATP synthase. S. pseudintermedius 
can also respire anaerobically using nitrate and nitrite reductase complexes that reduce NO3− to NO2− and NH3.
Despite the observations above, which predict an increase in cellular NADH and FADH2 pools, we did not 
observe a marked alteration in the expression of genes encoding the respiratory chain. The FMN-dependent 
NADH:quinone azoreductase acpD, one of 15 genes encoding the NADH dehydrogenase complex, was however 
significantly upregulated. The AcpD protein plays an important role in removing electrons from NADH and 
passing them to the electron transfer chain. Cytochrome b (sdhC), one of three succinate dehydrogenase subu-
nits from complex II was also significantly upregulated in response to CPF, although this complex participates 
only in electron passage without proton pumping. Expression of all 4 subunits (qoxABCD) of terminal oxidase 
was not significantly affected by CPF. In common with S. aureus8, S. pseudintermedius has a branched electron 
transfer chain. In addition to the aforementioned constituents of complex IV, which are required under aerobic 
conditions, it also possesses the cytochrome bd menaquinol oxidase cydAB that is expressed under microaerobic 
conditions. This oxidase was significantly downregulated in the presence of CPF.
Nitrate and nitrite serve as alternatives to oxygen terminal electron acceptors. We found that both nitrate 
(narHJ) and nitrite (nirD) reductase components were downregulated by CPF as well as nitrate ABC transporter 
substrate-binding protein (UH47_12325) and formate/nitrite transporter nitrate (UH47_08305) transport-
ers. The only exception was upregulation of the nitrate transporter (narT). No genes for molybdenum cofactor 
(Moco) biosynthesis, required for the reduction of nitrate to nitrite9, were identified as being differentially regu-
lated, and the entire F0F1 ATP synthase complex (atpBEFHAGDC) and ATP-binding protein (atpI) were similarly 
unaffected by CPF in comparison to the control culture.
Arginine metabolism. As summarised in Table 2, consistent upregulation was detected for most of the 
genes encoding enzymatic steps of conversion between 2-oxoglutarate precursor and arginine via glutamate, 
glutamate 5-semialdehyde, 1-pyrroline-5-carboxylate, ornithine and citruline (including branches from 
1-pyrroline-5-carboxylate to proline by proline dehydrogenase (UH47_08665) and from ornithine to proline 
by ornithine cyclodeaminase (UH47_00790). Conversion between glutamate and glutamine (by glutamine syn-
thetase glnA) was downregulated at both RNA and protein levels. Octopine degradation by octopine dehydro-
genase (odh) was upregulated. This reaction provides arginine, and in addition one molecule of pyruvate and 
NADH. Catabolic reactions of arginine, catalysed by ornithine carbamoyltransferase (arcB) and arginine deimi-
nase (arcA), were also upregulated. This pathway, called the arginine deiminase pathway (ADI), results in ATP 
formation.
Lipid catabolism. The first step of triacylglycerides degradation is the hydrolysis of the ester bonds for break-
down to glycerol and three fatty acids. Exposure to CPF resulted in upregulation of triacylglycerol lipase (lip) that 
catalyses this reaction. One of the top upregulated genes (FC = 16.4) was the long-chain fatty acid-CoA ligase 
acsL, which activates the breakdown of complex fatty acids. This is the pre-step reaction of β-oxidation that abun-
dantly provides acetyl-CoA to the TCA cycle.
CPF exposure increases the rate of cellular ethidium bromide (EtBr) incorporation.  Integrated 
analysis of the transcriptome and proteome data suggests CPF causes changes in NADH and ATP generation. 
This and the fact that synergy is specific only for tetK-mediated resistance suggests that CPF affects membrane 
energetics. To evaluate the effects of CPF on the bacterial membrane and its PMF energy, the rate of EtBr incor-
poration was studied in MRSP E104. Under normal conditions, PMF-dependent efflux pumps maintain low 
intracellular concentrations of EtBr10,11. Any factors contributing to a loss of membrane integrity, PMF energy 
or efflux pump functions cause a higher rate of intracellular EtBr accumulation, resulting in an increase of EtBr 
fluorescence. EtBr fluorescence increased with increasing CPF concentrations (Fig. 1a) and the initial rate of 
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increment for the first 30 seconds was approximately 4 times higher upon exposure to 64 µg/ml of CPF than in 
the control (Fig. 1b).
cpf dissipates the cytoplasmic membrane pMf. We used a membrane-specific fluorescent dye, 
3,3′-Dipropylthiadicarbocyanine iodide (DiSC3(5)), to determine the effect of CPF on PMF. PMF or pro-
tonic potential difference (Δp) of bacterial membrane comprise of two parts, electrochemical potential (ΔΨ) 
and pH difference between inside and outside (ΔpH). All three components are tethered by the Nernst equa-
tion, Δp = (ΔΨ) − 2.303RT/nF(ΔpH)12. Studying the effect of CPF on DiSC3(5) fluorescence, which localizes 
in the bacterial membrane in a ΔΨ dependent manner, illustrated the action of CPF on membrane energy. 
Membrane localization of DiSC3(5) decreases its fluorescence and PMF dissipation releases DiSC3(5) from 
membrane to media and increases its fluorescence13. DiSC3(5) fluorescence increased upon exposure to CPF 
(Fig. 2a) and the increase in fluorescence was proportional to the concentration of CPF (Fig. 2b). A similar 
result was observed when DiSC3(5)-labelled cells were exposed to a known proton translocator, carbonyl cya-
nide 3-chlorophenylhydrazone (CCCP), whereas no change in fluorescence was observed in the control sample 
(Fig. 2a). These observations indicate that CPF dissipates the ΔΨ of the cytoplasmic membrane.
CPF acidifies the cellular cytoplasm.  The effects of CPF on ΔpH change with the dissipation of the 
ΔΨ upon CPF exposure was studied using a cytoplasm specific fluorophore, 2′,7′-Bis(2-carboxyethyl)-
5(6)-carboxyfluorescein acetoxymethylester (BCECF-AM). It is known that upon entering into the cytoplasm 
BCECF-AM is hydrolysed by a cytoplasmic esterase to produce the BCECF fluorophore14. The fluorescence of 
BCECF is dependent on the pH of the cytoplasm. While under normal conditions the cytoplasmic pH is alkaline 
and BCECF fluorescence is high, a reduction in the fluorescence signal is expected following acidification of 
the cytoplasm due to influx of H+ via proton translocation15. A marked reduction in BCECF fluorescence was 
observed upon exposure to CPF or known proton translocators such as nigericin and CCCP (Fig. 3a). The cyto-
plasmic acidification induced by CPF was comparable to those caused by nigericin and CCCP (Fig. 3b).
co-administration of DoX with cpf alters the cpf-dependent gene expression programme. 
A total of 1594 genes changed expression profile at the transcript level upon exposure to CPF/DOX. Of these, 
1058 genes were affected after 30 min and 1440 after 90 min with 903 genes being common to both time 
points (Table 1). Using the interaction Eq. (1) (see Material and Methods), we identified 485 genes with an 
interaction fold change (FCI) value significantly different from the sum of FCs for CPF and DOX separately 
(Supplementary Table S1). After 90 min exposure, 480 genes were interactively regulated, with 20 of these also 
identified at the 30 min time point. Only five genes were exclusively regulated after 30 min (phosphoglyceromu-
tase, gpmI; triosephosphate isomerase, tpi; phosphoglycerate kinase, pgk; central glycolytic genes regulator, cggR; 
Figure 1. EtBr incorporation rate increases with increasing concentrations of CPF. (a) EtBr fluorescence 
spectra of CPF-exposed and control cells during 3 min exposure. (b) Average EtBr fluorescence increment 
following exposure to different concentrations of CPF. A two-tailed t-test between control and samples was 
performed, significant difference with p < 0.05 is highlighted by asterisk.
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phosphoribosylformylglycinamidine synthase, UH47_09860). These were all upregulated and 4 out of 5 have 
predicted roles in glycolysis/gluconeogenesis (Table 2).
At the protein level, 60 genes were identified using the interaction formula analysis and 15 of them overlapped 
with the transcriptomic results. Two genes, pyridoxal biosynthesis protein (pdxS) and serine hydroxymethyltrans-
ferase (glyA), were regulated with unmatching direction, i.e. they were upregulated at the transcriptomic level 
but downregulated at the proteomic level. The complete list of interactively regulated genes is shown in Table S1.
Two types of interactive regulation were observed: FCCPF/DOX and FCI values had either the same (type 1) or 
the opposite (type 2) regulation direction. Several steps of the TCA cycle were interactively downregulated (gltA, 
icd, acnA, fum, sdhC). This pathway was downregulated by DOX, whereas it was upregulated by CPF alone with 
even higher absolute FC. Despite this upregulation, values calculated for both FCCPF/DOX and FCI indicated down-
regulation, indicating that both drugs together potentiate the effect of DOX instead of neutralising each other 
(type 1 interactive regulation).
Importantly, sucD generating ATP and malate dehydrogenase (mqo) producing NADH were interactively 
downregulated, as detected at the protein level. Moreover, several additional TCA enzymes up- or unregulated by 
CPF were interactively downregulated (sucA, sucB, sucC, sdhA, sdhB). Another important finding is that expres-
sion of ATP synthase, that was uninfluenced under exposure to CPF, was found to decrease when CPF and DOX 
were used in combination. We detected downregulation of three subunits of F0 (A,B,C) and F1 (β, ε, interactive: 
α, γ, σ) responsible for generating ATP. Moreover, two enzymes (dihydroxynaphthoic acid synthetase, menB; 
2-succinyl-6-hydroxy-2, 4-cyclohexadiene-1-carboxylate synthase, menH) in the biosynthesis pathway of men-
aquinone (the electron carrier in respiratory chain) were also downregulated.
Pyruvate dehydrogenase (pdhA) unregulated by CPF was also interactively downregulated. The AckA protein, 
which activates acetate for conversion to pyruvate, interactively decreased in abundance as detected by proteom-
ics. Almost all alternative carbon source genes (except the gene for melobiose) were very weakly or not upregu-
lated by CPF/DOX despite being very highly upregulated by each drug individually, thus resulting in a negative 
FCI (type 2 interactive regulation).
One of the strongest interactively downregulated pathways was tryptophan synthesis from chorismate 
(detected for trpABCDGF and trpA on protein level). Arginine conversion pathways (including gdhA, rocD; 
1-pyrroline-5-carboxylate dehydrogenase, UH47_09200 and glutamate-1-semialdehyde aminotransferase, 
hemL) and peptide ABC transporter consisting of subunits UH47_06450 and UH47_06455 were also interac-
tively downregulated. Importantly, carbamate kinase (arcC), which generates ATP molecule during arginine 
utilisation, was interactively downregulated on the protein level in addition to arcA and arcB downregulated 
on transcript level. Proteomics analysis also showed interactive downregulation of various proteins related to 
stress responses (protease, clpP; catalase, katE; ribosome-associated translation inhibitor, raiA; alkaline shock 
protein 23, UH47_11605; universal stress protein, UH47_02170; phoP family transcriptional regulator, phoB). 
UH47_02170, phoP and phoB were also downregulated at the transcriptional level.
Figure 2. CPF treatment dissipates the PMF of E104. (a) DiSC3(5) fluorescence spectra and the effects of 
individual CPF or CCCP treatments on DiSC3(5) fluorescence. (b) Average DiSC3(5) fluorescence increases 
upon exposure to CPF or CCCP. A two-tailed t-test between control and samples was performed, significant 
difference with p < 0.05 is highlighted by asterisk.
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Proteomic analysis revealed that elongation factor Tu (tuf), which was downregulated by DOX (Supplementary 
Table S1), was even more downregulated by the combination of the two drugs. Only one ribosomal subunit (30S 
S2, rpsB) was detected as being interactively downregulated. In this case both CPF and DOX upregulated this 
subunit and also FCCPF/DOX was positive but not so high as it would be expected after summing the effects of each 
drug (type 2 interactive regulation). Most of the ribosomal subunits (30S S6, rpsF; 50S L7/L12, rplL; 50S L25, rplY; 
50S L10, rplJ) detected by proteomics had positive FCCPF/DOX and FCI values. We also found three interactively 
upregulated tRNA ligase genes (valS, alaS, UH47_11775).
CPF and DOX in combination interactively increased expression of tetK and interestingly also the TetR fam-
ily transcriptional regulator (UH47_08515), whereas sub-inhibitory concentration of DOX alone did not affect 
expression of these genes and CPF downregulated both (Table 2).
CPF and DOX synergistically inhibit protein but not DNA synthesis.  Macromolecule biosynthesis 
assays using radiolabelled 3H-Thymidine (DNA precursor) and 3H-leucine (protein precursor) were performed to 
measure the rate of DNA and protein synthesis in the presence of CPF and DOX, used individually and in combi-
nation. A 50% reduction in the rate of DNA synthesis was observed when cells were exposed to 32 µg/ml of CPF 
(Fig. 4). No marked change in the rate of DNA synthesis was observed when cells were exposed to 0.5 µg/ml of DOX. 
The same concentration of DOX did not show any additional effect on DNA synthesis when cells were exposed to the 
two drugs in combination. The rate of protein synthesis was reduced by only 20% and 10% upon exposure to DOX 
and CPF alone, respectively, whereas a reduction of 75% was observed following simultaneous exposure to both 
drugs (Fig. 4).
Discussion
cpf is a proton translocator. The CPF-dependent changes in gene expression identified using transcriptomics 
and proteomics are consistent with a role for CPF in compromising membrane bioenergetics. This hypothesis was 
confirmed by our biophysical experiments, which demonstrated that CPF acts as a proton translocator. This conclu-
sion is based upon three observations when TetK-positive MRSP are exposed to CPF: i) the high EtBr incorporation 
showing activity of CPF on the cytoplasmic membrane, ii) the DiSC3(5) fluorescence increment documenting its 
ionophore activity, and iii) the BCECF fluorescence drop supporting its proton carrier activity. The ability of CPF to 
cause proton translocation across cellular membranes is also consistent with the recent finding that this drug causes 
an oxidative stress response in the mitochondria of the canine dog mucosal cells16. Mitochondrial and bacterial mem-
branes are known to be similar17. Compared to CCCP, CPF is a weaker dissipator of PMF since a similar ΔpH dissi-
pation was obtained by exposure to 20 µM of CCCP and 234 µM of CPF (64 µg/ml), indicating that CCCP is almost 
ten times more efficient as a proton carrier compared to CPF. The proton translocation function of CCCP is due to 
its weak acid property18 and the chemical structure of CPF suggests that the mechanism involved could be the same, 
even though the number of proton carrying moieties in CPF is lower compared to CCCP (Supplementary Figure S2).
Figure 3. CPF carries proton. (a) BCECF fluorescence spectra and the effects of individual exposure to CPF, 
nigericin or CCCP on BCECF fluorescence. (a) BCECF fluorescence changes as a result of CPF, nigericin or 
CCCP exposure. A two-tailed t-test between control and samples was performed, significant difference with 
p < 0.05 is highlighted by asterisk.
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Metabolic compensation strategy for cpf-induced pMf depletion. The potential energy of the 
membrane PMF is used for the synthesis of ATP in the process of oxidative phosphorylation. This process is much 
more efficient than substrate phosphorylation, which is only a secondary process to gain ATP19. Muthaiyan et. 
al.20 reported that S. aureus strongly upregulates expression of all genes exclusively encoding glycolytic enzymes 
(with no impact on gluconeogenesis) to compensate for depletion of PMF after 15 min of exposure to CCCP. 
We did not observe this type of compensation after 30 and 90 min exposure to CPF. In contrast to S. aureus, S. 
pseudintermedius does not possess an enzymatic system to hydrolyse and metabolise starch (according to KEGG 
PATHWAY Database)21, the main carbohydrate source in cation adjusted Mueller-Hinton broth (CAMHB), the 
medium used in both studies. It can be hypothesised that during growth in CAMHB, MRSP first metabolises 
the residual glucose present in the formulation before switching to peptides/amino acids. After 90 min exposure 
to CPF, when residual glucose was exploited, we observed a pattern of gene regulation typical of inactivation of 
carbon catabolite repression22. This included downregulation of glucose uptake and upregulation of several alter-
native carbohydrate carbon source uptake and activation systems. Glycolytic substrate phosphorylation can run 
on alternative carbon compounds23,24 but this was evidently not a primary energy compensation strategy because 
it would require activation of fermentation to regenerate NAD+, which was not observed. Downregulation of 
two glycolytic enzymes and upregulation of only one enzyme that increases the pool of NADH supports this 
proposal. Instead, we observed an increase in reactions and transport processes providing substrates for, and 
regenerating intermediates of, the TCA cycle, i.e. pyruvate from lactate, acetyl-CoA from acetate, acetonin and 
most significantly from lipid degradation, oxoglutarate from histidine (and probably other amino acids since we 
observed upregulation of many peptide transporters, oligo- and aminopeptidases, and CAMHB medium is rich 
in peptides); and succinate, fumurate and malate via the C4-dicarboxylate transporter. We also detected very 
consistent upregulation of the TCA cycle. This matches the observed upregulation of respiratory complex I and II. 
In some organisms, the activity of chain components can also be allosterically inhibited by ATP25 that is presum-
ably reduced under CPF exposure. Altogether, these findings suggest that MRSP attempts to compensate for the 
proton translocation mediated by CPF by sending protons from overproduced NADH to the extracellular space.
Interestingly, we found that the arginine utilisation pathway was notably upregulated in response to CPF. 
Arginine can be generated from increased octopine degradation26 and from putrescine since its uptake was also 
upregulated. Energy depletion and arginine upregulate the catabolic ADI pathway and that provides ATP27. Many 
bacteria exploit arginine as an energy source by this pathway28,29. Thus, upregulation of this pathway could also be 
an alternative energy strategy used by MRSP to compensate for the action of CPF.
cpf acts in synergy with DoX to inhibit protein synthesis. CPF induces synergistic protein synthesis 
inhibition in combination with DOX in tetK-mediated DOX-resistant MRSP ST71 (Fig. 4). This suggests that 
cytoplasmic levels of DOX, which depend on the activity of the TetK efflux pump, increase in the presence of CPF. 
The TetK pump exports DOX out of cells in exchange for H+ ions30,31. Hence, the most likely mechanism behind 
the observed CPF/DOX synergy in tetK-mediated DOX-resistant strains is that CPF’s PMF dissipation inacti-
vates the TetK efflux pump and indirectly increases the cytoplasmic levels of DOX, which in turn inhibits protein 
synthesis and cell growth. Proteomics analysis revealed decreased expression of RaiA, a ribosome-associated 
translation inhibitor, whereas expression of many ribosomal subunits increased under exposure to the drugs in 
combination. The latter could be a consequence of the loss of DOX-inhibited ribosomal subunits.
The PMF dissipation action of CPF inactivates the TetK efflux pump (the cause of DOX resistance), which 
indirectly increases the cytoplasmic DOX levels and consequently inhibition of protein synthesis. Nevertheless, 
reduction of ΔpH by CPF simultaneously reduces the pH gradient dependent diffusion of DOX into the cytoplasm 
since cellular uptake of DOX depends on the ΔpH of the cytoplasmic membrane32. Thus, CPF-mediated PMF 
Figure 4. CPF-DOX combination inhibits protein synthesis synergistically. Percentages of radiolabelled DNA 
and protein precursors incorporation compared to unexposed control are presented as average values of two 
individual measurements. DNA and protein synthesis panels are designated by line and labelled as DNA and 
Protein. A two-tailed t-test between control and samples was performed, significant difference with p < 0.05 is 
highlighted by asterisk.
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dissipation has both positive and negative effects on the antimicrobial activity of DOX. Simultaneously it inhib-
its the TetK efflux pump (positive effect) and reduces the diffusion of DOX inside the cell (negative effect). This 
explains the moderate synergy (ΣFICI = 0.325) that we observed between DOX and CPF in our previous study18.
interference between cpf and DoX pathways abrogates compensation of pMf depletion. 
Transcriptomic and proteomic profiling clearly showed that presence of DOX, even at a sub-inhibitory concentra-
tion, substantially interferes with the metabolic strategy to restore energetic balance in the presence of CPF. CPF 
regulates only 12% of the genes of the genome. The number of genes regulated by DOX is close to the number of 
genes regulated by CPF/DOX used in combination, approximately 60%. Despite this, DOX has limited effects on 
the growth of MRSP. However, when MRSP is exposed to the two drugs in combination, the crosstalk between 
these unmanifested (in regards to viability) alterations with metabolic adaptation to CPF is fatal for the bacteria. 
Most importantly, (I) the interactions are strongly reflected in downregulation of the entire TCA cycle that is the 
core of carbon metabolism. Consequently, the influx of TCA substrate acetyl-CoA from many reactions as well 
as regeneration of TCA intermediates mainly by lipid and histidine degradation were either not upregulated in 
comparison to CPF exposure alone or interactively downregulated. (II). The drug interactions cause downreg-
ulation of all subunits of ATP synthase. By these two alterations in metabolic adaptation to CPF bacterial cells 
lose the opportunity to overproduce NADH and ATP to compensate for PMF depletion. This is supported by the 
fact that the phosphate starvation regulator PhoP, which is normally expressed in response to a lack of inorganic 
phosphate33, was downregulated following exposure to CPF and DOX. Since ATP production decreases, there is 
no inorganic phosphate deficit. The mechanism proposed to explain the action of CPF and the synergy between 
CPF and DOX is illustrated in Fig. 5.
conclusions
This study demonstrates that CPF is a proton translocator that paralyzes PMF-dependent efflux of DOX medi-
ated by TetK, thereby allowing intracellular DOX concentrations that are required for inhibition of protein syn-
thesis. PMF depletion induced by CPF challenges oxidative phosphorylation, while energy balance is sustained 
by metabolic adaptations. Interference between CPF and DOX pathway alterations abrogates this energetic 
compensation.
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Figure 5. Proposed mechanism of action of CPF alone and in combination with DOX. The figure illustrates the 
proposed mechanism of action of CPF alone (left) and in combination with DOX (right), including the most 
consistently regulated pathways related with energy metabolism. The bars indicate a gene regulation mode in 
the drawn metabolic pathways. They contain square (left) representing CPF and rectangle (right) representing 
CPF/DOX interactions. Green in bars indicates upregulations and red upregulation.
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Materials and Methods
Bacterial strain.  MRSP ST71 E1043 was used as a model strain for investigating the mechanism of syn-
ergy between CPF and DOX. Genomic DNA extraction was performed using MasterPure™ Gram Positive 
DNA Purification Kit (Epicenter). A de novo whole genome sequencing library was created using the Nextera 
XT DNA Library Preparation Kit (Illumina). The library was run with a 250-bp paired-end read module using 
the MiSeq platform. The average depth of sequencing coverage was 121. The reference genome was annotated 
using the Prokaryotic Genomes Automatic Annotation Pipeline (PGAAP)34 developed by the National Center for 
Biotechnology Information (NCBI). The reference genome sequence for MRSP E104 is available at NCBI under 
the accession number: LAWU00000000. The transcriptome and proteome analyse is based on the annotations 
available for this genome on 05 July 2015.
Culture conditions and experimental design for protein and RNA sampling.  Overnight culture 
was diluted to an OD600 of 0.05 in CAMHB and re-grown to OD600 0.4 (108 CFU/ml) in the same medium. A main 
culture was initiated by diluting this pre-culture 1:1000 (105 CFU/ml) in three replicate flasks (5 L, 1050 ml in 
each). At an OD600 of 0.1 (107 CFU/ml) every replicate culture was split into set of four flasks (1 L, 250 ml in each). 
Three cultures in each set were exposed to DOX (0.5 µg/ml), CPF (32 µg/ml) or both compounds (0.5/32 µg/ml) 
and further incubated with an untreated control. As CPF was used as a dimethylsulfoxide (DMSO) solution, all 
cultures including controls were adjusted to have an equal final DMSO concentration (≤0.4%). OD600 of all cul-
tures was measured every hour for the next 12 h. All cultures were incubated at 37 °C and 180 rpm. 45 ml aliquots 
of each culture were collected after 90 min of exposure, pelleted and washed once with saline. Cultivation and 
treatment procedures were reproduced for RNA extraction. 6–9 ml aliquots of each culture were collected after 30 
and 90 min of exposure. Samples were immediately suspended in RNA Protect solution (twice the amount of cul-
ture, QIAGEN), incubated for 5 min and centrifuged at 4000 rpm for 10 min at room temperature. Supplementary 
Figure S1 summarise experimental plan for the expression study including sample numbers, exposure times and 
conditions.
RNA sequencing and read mapping.  Total RNA was extracted from MRSP E104 cells using an RNeasy 
Mini Kit (Qiagen) by adapting the manufacturer’s instructions to own settings. Cells were lysed in the presence of 
300 mg acid-washed glass beads (150–600 μm diameter, Sigma) per sample using a Fast Prep Lyser (Eppendorf) 
with three cycles of 1 min at maximum speed and one cycle of 7 min, cooling the samples on ice for 2 min before 
and between cycles. The cooling on ice was used to prevent unwanted heating during RNA extraction. On col-
umn DNA digestion was performed using the RNase-Free DNase Set kit (Qiagen). The integrity of the RNA 
after isolation was verified using a NanoDropTM (absorbance ratios 260/280 nm and 260/230 nm ≥ 1.8) and a 
Bioanalyzer 2100 (RNA Integrity Number (RIN) ≥ 7). Samples of total RNA (≥5 µg, measured on a Qubit) were 
submitted for transcriptome sequencing at a commercial provider (Beijing Genomics Institute, BGI) using an 
Illumina HiSeq. 2000 machine with TruSeq V3 sequencing kits. Prior to sequencing, all samples were treated 
with DNaseI (New England Biolabs® Inc) and then enriched for mRNA molecules via ribosome-depletion using 
the Ribo-Zero™ magnetic Kit for bacteria (Epicentre). A quality control of the reads was done by a standard 
procedure performed at BGI using the software SOAPnuke35 and confirmed by the FastQC software (https://
www.bioinformatics.babraham.ac.uk/projects/fastqc/). The reference genome sequences of S. pseudintermedius 
strain E104 is available at NCBI under the accession numbers: LAWU00000000. The RNA-sequencing reads are 
available in the Short Read Archive (SRA) at NCBI under the accession numbers: SRX3206467 to SRX3206493. 
Library construction was done using a prokaryotic transcriptome library construction protocol (developed by 
BGI). Sequenced reads (>10 million paired-end 90 nt reads per sample) were mapped to the reference genome 
using TopHat v2.0.1436 employing the default settings but with splice awareness turned off. Mapped reads were 
processed and analysed in R37. Reads mapping to annotated genome features were counted using Rsubread38, 
disallowing duplicate reads and reads that map to more than one location. Reads overlapping adjacent genes were 
counted for each gene. Genes exhibiting generally low transcript counts were filtered out from the downstream 
analysis (9 genes removed), retaining transcripts with > 0.5 counts per million (cpm) in at least 3 of the samples.
Protein extraction and two-dimensional differential in-gel electrophoresis (2D DIGE).  E104 
cells were lysed by lysostaphin (30 min at 37 °C) and three rounds of liquid nitrogen frozen/thawed in presence 
of protease inhibitor (GE Life Sciences, as all following reagents, kits, devices and software in this paragraph). 
Lysates were treated with nuclease (40 min at room temperature). Next, proteins were purified via 2D Clean-up 
Kit, solubilized in DIGE buffer (7 M urea, 2 M thiourea, 4% CHAPS, and 30 mM Tris-HCl) and protein concen-
trations determined using the 2D Quant Kit. The CyDye DIGE Fluor minimal dyes, Cy3 or Cy5, were used to 
label all treated samples and untreated control (50 μg of protein each) according to Ettan DIGE System manual. 
To eliminate dye-specific bias, all types of samples were dye-swapped by labelling with both Cy3 and Cy5. Internal 
standard was prepared by mixing aliquots of every protein sample (25 μg from each) and labelled with Cy2. 
Protein samples were combined in pairs and mixed together with an aliquot of internal standard, and supple-
mented with 1% dithiothreitol, 1% IPG buffer pH 4–7 and 0.02% bromophenol blue.
Prior to isoelectric focusing (IEF), IPG strips (pH 4–7, 24 cm) were rehydrated in DeStreak rehydration solu-
tion with 0.5% IPG buffer pH 4–7 overnight. The samples were applied using the cup-loading method and IEF 
was performed at a total of 50 kVh per stripe on Ettan IPGphor. IPG strips were subsequently reduced, alky-
lated (15 min each) and proteins were separated in the second dimension with 12.5% SDS-PAGE gels on Ettan 
DALT six Electrophoresis Unit according to manual. Immediately after the second dimension, gels were imaged 
at excitation/emission wavelengths of Cy2 (488/520 nm), Cy3 (532/580 nm), and Cy5 (633/670 nm) at 100 μm 
resolution by using Typhoon 9500 Variable Mode Imager. The obtained images were exported as 16-bit GEL files. 
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Spots on separate gels were detected and analysed using Difference In-gel Analysis (DIA) module and matched 
between gels using BVA module within DeCyder Image Analysis Software v 7.0 software. Comprehensive Ettan 
DIGE System user manual can be accessed on https://www.mcgill.ca/cian/files/cian/ge_dige_manual.pdf.
Protein identification.  Prior to spot identification, gels were stained with Sypro Ruby (Sigma-Aldricht) 
according to the manufacturer manual. Selected spots qualified based on interaction formula described in next 
paragraph were manually excised and subjected to in-gel digestion using Trypsin (Sigma-Aldricht) following 
the manufacturer’s instructions. Next, peptides were isolated from gel spots (by H2O, trifluoroacetic acid and 
acetonitrile solutions) and purified by RP C18 chromatography (μZipTip, Millipore). Peptides extracted from 
protein spots were analysed by an EASY-nLC mounted with an EASY-Spray column (PepMap, C18, 3μm, 100 Å, 
75 μm × 15 cm) coupled with a Q Exactive Biotech mass spectrometer (both Thermo Fisher Scientific). Buffer 
A consisted of 0.1% formic acid (FA) in water, and buffer B was 0.1% FA in 99% acetonitrile. 5 µl of sample were 
injected. The flowrate was 100 nl/min and the gradient consisted of linear increase from 0% to 30% B in 30 min. 
On-line MS/MS spectra were recorded in the positive mode using the Full MS method with a resolution of 70000, 
an AGC target of 3e6, max IT of 50 ms and a mass range from 200 to 2000 m/z. The top 7 spectra from the MS 
were analysed using the dd-MS2 method, with a resolution of 35000 and AGC target of 1e6. Mass spectra of pro-
teins were exported and compared to the whole MRSP E104 proteome using Proteome Discoverer software (v 
1.4, Thermo Fisher Scientific). The search method used was Sequest HT, with precursor mass tolerance 10 ppm 
and fragment mass tolerance set to 0.05 Da, static modification carbamidomethyl + 57.021 Da for cysteine. The 
target Decoy PSM validator was used as validation method. The top score identified proteins for every spot were 
selected. Identification details for selected protein spots are listed in Supplementary Table S2. The MS data and 
the preparative gel picture have been deposited to the ProteomeXchange Consortium via the PRIDE38 repository 
with the dataset identifier PXD013725.
Analysis of gene expression data.  Normalized values for transcript and protein abundance in the log2 
scale were obtained from the transcriptomic data by Trimmed Mean of M values (TMM) normalization39,40 and 
from the proteomic data by transforming protein pick volumes using Decyder. Normalized values for all individ-
ual exposure conditions (DOX, CPF, DOX-CPF) were tested for differential expression by comparing against the 
control (no exposure) sample taken at the corresponding time point. Testing was performed in R using LIMMA 
linear modelling, applying the LIMMA voom method40 to both the RNA-seq and 2D DIGE data, and calculating 
adjusted P-values using the Benjamini and Hochberg multiple testing correction. In order to identify changes 
in gene expression associated with the synergistic interaction of CPF and DOX, a null hypothesis based on a 
multiplicative interaction model41 was assumed. Thus, for example, a transcript or protein that exhibits a 2-fold 
reduction in abundance following CPF exposure and also a 2-fold reduction following DOX exposure, is expected 
to show a 4-fold reduction following exposure with both CPF and DOX in combination. In the log scale, this can 
be represented by the following Eq. (1), where NA corresponds to normalized abundance:
− − − + − =− (1)(Log NA Log NA ) ((Log NA Log NA ) (Log NA Log NA )) 02 CPF DOX 2 Control 2 DOX 2 Control 2 CPF 2 Control
Significant deviations from the null hypothesis are represented by an interaction score Log2FCI calcu-
lated using the same equation (where Log2FCI = 0 indicates no interaction), and are defined by an adjusted 
P-value ≤ 0.05 and Log2FCI ≥ 1 or ≤ −1 (2-fold change limit) for transcript abundance, and an adjusted 
P-value ≤ 0.05 and Log2FCI ≥ 0.585 or ≤ −0.585 (1.5-fold change limit) for protein abundance.
protein annotation and pathway prediction. Altered pathway prediction for differentially expressed 
genes as an input was performed with support of geneGO42 annotations, Kyoto Encyclopedia of Genes and 
Genomes (KEGG_PATHWAY)21, BioCyc43 and String44 However, due to weak NCBI annotation application 
of the listed bioinformatics tools for S. pseudintermedius genomes, most of the annotation and pathway recon-
struction was performed or refined manually by BLAST analysis and literature searches based on closely related 
species.
Measurement of EtBr incorporation rate.  Measurement of EtBr incorporation rates was performed 
following a modified protocol from Bulathsinghala et al.45. Briefly, overnight culture of E104 was diluted 1:100 
in CAMHB (Sigma-Aldrich) and sub-cultured to reach an OD600 of 0.2. The culture was exposed to different 
concentrations of CPF (16, 32 or 64 μg/ml) for 5 min at room temperature before transferring into a cuvette and 
adding 10 µg/ml of EtBr. The EtBr fluorescence spectra were recorded in PerkinElmer LS50B fluorescence spec-
trometer at Excitation/Emission (Ex/Em) wavelengths 520 nm/590 nm for 3 min using time drive application 
of FLWINLAB software. Finally, EtBr fluorescence spectra over time were plotted as arbitrary fluorescence unit 
(FU). Linear fluorescence increment in initial 30 seconds (FU30sec - FU0sec) was multiplied by 2 to calculate the 
rate of fluorescence increment per minute (FU/min). Two-tailed t-test was used to detect significant differences 
between CPF-exposed and control samples. All probe-based experiments were performed with minimum two 
technical and two biological replicates.
comparative study of bacterial membrane potential. A fresh culture of E104 was diluted to OD600 of 
0.1 in CAMHB and cells were labelled with 1 µM DiSC3(5). The fluorescence spectra of labelled cells were taken 
at Ex/Em wavelengths 546 nm/573 nm as described previously46. After reading of initial stable DiSC3(5) spectra, 
labelled cells were treated with CPF (16, 32 or 64 μg/ml) or carbonyl cyanide 3-chlorophenylhydrazone (CCCP, 
0.05, 0.1 or 0.2 µg/ml), a known proton translocator (positive control). Changes in DiSC3(5) fluorescence over 
time (FUafter treatment − FUbefore treatment) were recorded and plotted.
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Measurement of cytoplasmic pH change. E104 was cultured in presence of 10 µg/ml of BCECF-AM, a 
pH-sensitive cytoplasm-specific dye, for 30 min at 30 °C. Incubated cells were pelleted down and re-suspended in 
phosphate buffer saline supplemented with 25 mM glucose adjusting OD600 to 0.2. The cell suspension was kept at 
room temperature for 1 hour to equilibrate the cytoplasmic pH and finally BCECF fluorescence was recorded at 
Ex/Em wavelengths 485 nm/520 nm. Nigericin and CCCP were used as positive controls in view of their known 
activity as proton translocators. After initial stable reading of BCECF spectra, labelled cells were treated with CPF 
(64 μg/ml), nigericin (20 μg/ml) and CCCP (4 μg/ml) individually, and changes in BCECF fluorescence between 
the time points 0.2 and 2.8 mins (FU2.8 min – FU0.2 min) were recorded and plotted.
Determination of macromolecule biosynthesis rates. Overnight E104 culture was diluted 1:100 in 
minimal medium (0.02 M HEPES, 0.002 M MgSO4, 0.0001 M CaCl2, 0.4% succinic acid, 0.043 M NaCl2, 0.5% 
(NH4)2SO4) supplemented with 5% tryptic soy broth (TSB) and sub-cultured to OD600 of 0.2. Grown cells were 
pelleted down by centrifugation and re-suspended in fresh minimal media followed by incubation with either 
DOX (0.5 µg/ml), CPF (32 µg/ml) or DOX/CPF combination (0.5/32 µg/ml) for 15 min. Incubated cells were 
pulse labelled for 20 min with 25 µl of radiolabelled DNA or protein synthesis precursors, (50 µCi) 3H-Thymidine 
or 3H-leucine (Ultima Gold, PerkinElmer), respectively. Finally, radiolabelled cells were precipitated with 
equal volume of 30% trichloroacetic acid (TCA) as described previously13,46. Precipitates were filtered on cel-
lulose membrane (cat no. AAWG0250C, Millipore) and washed by two sequential washes of ice-cold 15% TCA 
and two washes of ice-cold water. Filters were dried and stored in scintillation vials. 3 ml scintillation fluid was 
added to each vial and 3H count was taken in Beckman Coulter LS6500 liquid scintillation counter for 1 min. 
Macromolecule biosynthesis rates were calculated based on the assumption that the rates of DNA and protein 
precursor incorporation were 100% in the control sample.
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